Next Article in Journal
Use of Complete Clearance for Assessing Treatment Efficacy for 5-Fluorouracil Interventions in Actinic Keratoses: How Baseline Lesion Count Can Impact This Outcome
Previous Article in Journal
Health Economic Evaluation of Gene Replacement Therapies: Methodological Issues and Recommendations
 
 
Journal of Market Access & Health Policy (JMAHP) is published by MDPI from Volume 12 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Taylor & Francis.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Communication

Impact of Non-Medical Switching of Prescription Medications on Health Outcomes: An E-Survey of High-Volume Medicare and Medicaid Physician Providers

by
Craig Coleman
1,2,*,
Tabassum Salam
3,
Amy Duhig
4,
Aarti A. Patel
5,
Ann Cameron
4,
Jennifer Voelker
5 and
Brahim Bookhart
5
1
Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, USA
2
Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA
3
Medical Education, American College of Physicians, Philadelphia, PA, USA
4
Consulting Services, Xcenda, Palm Harbor, FL, USA
5
Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, FL, USA
*
Author to whom correspondence should be addressed.
J. Mark. Access Health Policy 2020, 8(1), 1829883; https://doi.org/10.1080/20016689.2020.1829883
Submission received: 8 June 2020 / Revised: 18 September 2020 / Accepted: 21 September 2020 / Published: 5 October 2020

Abstract

Background: Non-medical switching refers to a change in a stable patient’s prescribed medication to a clinically distinct, non-generic, alternative for reasons other than poor clinical response, side-effects or non-adherence. Objective: To assess the perceptions of high-volume Medicare and/or Medicaid physician providers regarding the impact non-medical switching has on their patients’ medication-related outcomes and health-care utilization. Methods: We performed an e-survey of high-volume Medicare and/or Medicaid physicians (spending >50% of their time caring for Medicare and/or Medicaid patients), practicing for >2 years but <30 years post-residency and/or fellowship; working in a general, internal, family medicine or specialist setting; spending ≥40% of their time providing direct care and having received ≥1 request for a non-medical switch in the past 12 months. Physicians were queried on 15-items to assess perceptions regarding the impact non-medical switching on medication-related outcomes and health-care utilization. Results: Three-hundred and fifty physicians were included. Respondents reported they felt non-medical switching, to some degree, increased side-effects (54.0%), medication errors (56.0%) and medication abandonment (60.3%), and ~50% believed it increased patients’ out-of-pocket costs. Few physicians (≤13.4% for each) felt non-medical switching had a positive impact on effectiveness, adherence or patients’ or physicians’ confidence in the quality-of-care provided. Non-office visit and prescriber-pharmacy contact were most frequently thought to increase due to non-medical switching. One-third of physicians felt office visits were very frequently/frequently increased, and ~ 1-in-5 respondents believed laboratory testing and additional medication use very frequently/frequently increased following a non-medical switch. About 1-in-10 physicians felt non-medical switching very frequently/frequently increased the utilization of emergency department or in-hospital care. Conclusion: This study suggests high-volume Medicare and/or Medicaid physician providers perceive multiple negative influences of non-medical switching on medication-related outcomes and health-care utilization.
Keywords: non-medical switching; medicare; medicaid; safety-net providers; vulnerable populations; outcome assessment non-medical switching; medicare; medicaid; safety-net providers; vulnerable populations; outcome assessment

Share and Cite

MDPI and ACS Style

Coleman, C.; Salam, T.; Duhig, A.; Patel, A.A.; Cameron, A.; Voelker, J.; Bookhart, B. Impact of Non-Medical Switching of Prescription Medications on Health Outcomes: An E-Survey of High-Volume Medicare and Medicaid Physician Providers. J. Mark. Access Health Policy 2020, 8, 1829883. https://doi.org/10.1080/20016689.2020.1829883

AMA Style

Coleman C, Salam T, Duhig A, Patel AA, Cameron A, Voelker J, Bookhart B. Impact of Non-Medical Switching of Prescription Medications on Health Outcomes: An E-Survey of High-Volume Medicare and Medicaid Physician Providers. Journal of Market Access & Health Policy. 2020; 8(1):1829883. https://doi.org/10.1080/20016689.2020.1829883

Chicago/Turabian Style

Coleman, Craig, Tabassum Salam, Amy Duhig, Aarti A. Patel, Ann Cameron, Jennifer Voelker, and Brahim Bookhart. 2020. "Impact of Non-Medical Switching of Prescription Medications on Health Outcomes: An E-Survey of High-Volume Medicare and Medicaid Physician Providers" Journal of Market Access & Health Policy 8, no. 1: 1829883. https://doi.org/10.1080/20016689.2020.1829883

APA Style

Coleman, C., Salam, T., Duhig, A., Patel, A. A., Cameron, A., Voelker, J., & Bookhart, B. (2020). Impact of Non-Medical Switching of Prescription Medications on Health Outcomes: An E-Survey of High-Volume Medicare and Medicaid Physician Providers. Journal of Market Access & Health Policy, 8(1), 1829883. https://doi.org/10.1080/20016689.2020.1829883

Article Metrics

Back to TopTop